Erythrocyte-active agents and treatment of sickle cell disease
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38 (4) , 324-332
- https://doi.org/10.1016/s0037-1963(01)90026-5
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Nitric Oxide-Mediated Heme Oxidation and Selective β-Globin Nitrosation of Hemoglobin from Normal and Sickle ErythrocytesBiochemical and Biophysical Research Communications, 2000
- The Feasibility of Pharmacological Volume Control of Sickle Cells is Dependent on the Quantization of the Transport Pathways. A Model StudyJournal of Theoretical Biology, 1999
- Peroxidative damage in sickle-cell erythrocyte ghosts: protective effect of allopurinolGeneral Pharmacology: The Vascular System, 1997
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sicklingBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- A Study of Induced Hyponatremia in the Prevention and Treatment of Sickle-Cell CrisisNew England Journal of Medicine, 1980
- Sickle-Cell Anemia: Molecular and Cellular Bases of Therapeutic ApproachesNew England Journal of Medicine, 1978
- Inhibition of sickling by methyl acetimidateFEBS Letters, 1976
- Crystal structure of sickle-cell deoxyhemoglobin at 5 Å resolutionJournal of Molecular Biology, 1975
- The function of calcium in the potassium permeability of human erythrocytesBiochimica et Biophysica Acta, 1958